PCR91 Patient Reported Outcomes in BRUIN CLL-321: A Phase 3 Trial of Pirtobrutinib Versus Idelalisib Plus Rituximab or Bendamustine Plus Rituximab in BTK Inhibitor Pretreated Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma
Abstract
Authors
Paul M. Barr Davide Rossi Emmanuelle Ferrant Fátima de la Cruz Dai Maruyama Versha Banerji Patrick Cobb Swathi Namburi Richard Greil Jeff P. Sharman Angely Loubert Kristin Creel Lisa M. Hess Nalin Payakachat Amy S. Ruppert Denise Wang Paolo B. Abada Ching Ching Leow Marisa Hill Catherine C. Coombs Paolo Ghia